Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Short-term Investments (2016 - 2018)

Lifecore Biomedical, Inc. \De\ has reported Short-term Investments over the past 6 years, most recently at $1.5 million for Q4 2018.

  • Quarterly results put Short-term Investments at $1.5 million for Q4 2018, up 66.34% from a year ago — trailing twelve months through Nov 2018 was $1.5 million (up 66.34% YoY), and the annual figure for FY2018 was $1.5 million, up 122.24%.
  • Short-term Investments for Q4 2018 was $1.5 million at Lifecore Biomedical, Inc. \De\, up from $1.5 million in the prior quarter.
  • Over the last five years, Short-term Investments for LFCR hit a ceiling of $1.5 million in Q2 2018 and a floor of $519000.0 in Q4 2016.
  • Median Short-term Investments over the past 3 years was $909000.0 (2017), compared with a mean of $1.0 million.
  • Peak annual rise in Short-term Investments hit 177.65% in 2018, while the deepest fall reached 66.34% in 2018.
  • Lifecore Biomedical, Inc. \De\'s Short-term Investments stood at $519000.0 in 2016, then soared by 75.14% to $909000.0 in 2017, then surged by 66.34% to $1.5 million in 2018.
  • The last three reported values for Short-term Investments were $1.5 million (Q4 2018), $1.5 million (Q3 2018), and $1.5 million (Q2 2018) per Business Quant data.